Navigation Links
Genetic Engineering & Biotechnology News reports on advances in miRNA
Date:2/29/2008

New Rochelle, NY, February 29, 2008 miRNA research is now one of the most interesting areas in the life science world, reports Genetic Engineering and Biotechnology News (GEN). Scientists around the globe are studying the effects of over- or underexpression of specific miRNAs on the development and inhibition of pathogenesis in a variety of diseases, according to an article titled miRNA-Regulated Pathways in the March 1 issue of GEN (http://www.genengnews.com/articles/chitem.aspx?aid=2382).

The appeal of miRNA technology lies in its promise and broad applicability across a wide spectrum of biotechnology and medical research, notes John Sterling, Editor-in-Chief of GEN. Increasing numbers of studies are focusing on conditions such as cancer, heart disease, and neurological disorders as well as on aging.

As more miRNAs are identified, researchers are correlating changes in miRNA levels with disease processes. For instance, scientists at the Wistar Institute recently identified miR-373 and miR-520c. Members of the same miRNA family, both were shown to promote tumor metastasis.

Also covered in the GEN article on miRNAs is research taking place at Asuragen, the University of Louisville, IBM, University of Texas Southwestern, Mira Therapeutics, and miRagen Therapeutics. In addition, GEN looks at the latest technologies and services from miRNA research enabling companies such as Exiqon, Sigma-Aldrich, Mirus Bio, Thermo Fisher Scientific, SuperArray Bioscience, and LC Sciences.


'/>"/>

Contact: John Sterling
jsterling@genengnews.com
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Page: 1

Related biology technology :

1. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
2. Honey bee invaders exploit the genetic resources of their predecessors
3. Genetic pathway critical to disease, aging found
4. CellCyte Genetics Corp. Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases
5. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
6. Smart Genetics Announces Plans to Launch a New Alzheimers Risk Assessment Service
7. Finkelstein Thompson LLP Announces Filing of Securities Fraud Class Action Against CellCyte Genetics Corporation
8. Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer
9. Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation
10. CellCyte Genetics Corp. Responds to Plaintiff Law Firm Press Releases
11. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... DUBLIN , March 30, 2017  Jazz Pharmaceuticals ... it has entered into license agreements with Nippon Shinyaku, ... Vyxeos ™ (cytarabine and daunorubicin liposome injection), or ... Under the terms of the agreements, Nippon Shinyaku will ... Vyxeos in Japan in return ...
(Date:3/29/2017)... ... March 29, 2017 , ... Zansors announced today its ... issued by the U.S. Patent & Trademark Office (USPTO). The patent covers a ... health monitoring. This invention will be critical to the future of wearable tech ...
(Date:3/29/2017)... 2017  Vermillion, Inc. (NASDAQ: VRML), a bio-analytical ... its results for the fourth quarter and full ... marked a pivotal year for us with our ... distribution agreements, major reimbursement progress with Medicare, positive ... In addition we cleared our 2 nd ...
(Date:3/29/2017)... COLORADO SPRINGS, CO , March 29, 2017 /PRNewswire/ - Last year,s ... who support kratom are not the only efforts active to generate ... that substitute opiate based pharmaceutical drugs in the healthcare market place. ... Earlier this ... U.S. based developer and distributor of pharmaceutical and nutritional products, announced ...
Breaking Biology Technology:
(Date:3/1/2017)... March 1, 2017  Aware, Inc. (NASDAQ: AWRE), a ... Richard P. Moberg has resigned, effective March ... Chief Financial Officer and Treasurer of Aware citing a ... as a member of the Board of Directors of ... co-Chief Executive Officer and co-President, General Counsel has been ...
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ... Iris-Scan, wird seine erstklassige biometrische Lösung zur ... 835 mit X16 LTE auf dem Mobile ... März) am Qualcomm-Stand in Halle 3, Stand ... beinhaltet die Sicherheitsplattform Qualcomm Haven™ – eine ...
(Date:2/24/2017)... BARCELONA, Spain , Feb. 24, 2017  EyeLock LLC, ... will demonstrate its elite iris biometric solution on ... with X16 LTE at Mobile World Congress ... in Qualcomm,s Booth in Hall 3, Stand ... contains the Qualcomm Haven™ security platform—a combination ...
Breaking Biology News(10 mins):